Abstract 5534: Analysis of <i>TERT</i> <i>mutant</i> circulating tumor DNA as a potential biomarker of disease activity in patients with unresectable stage III/IV melanoma receiving immuno-oncology therapies

Mahrukh M. Syeda, David Polsky, Melissa Wilson et al.|Cancer Research|2018

Cited by 1